United States · 
What does Genesis Capital invest in?
Genesis Capital invests most often at Series B and Venture (100% of the rounds on record), in sectors such as Cyber Security and Network Security.
Genesis Capital highlights
- 01
2 rounds on record
- 02
Mostly Series B and Venture: 100% of its rounds
- 03
Sole investor in 1 rounds, median $1.8M
- 04
1 exits from the portfolio
What they do
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- Cyber SecurityNetwork Security
- Based in
- Atlanta, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first2 appearances
- 2011
1 round
- Aug
- 2006
1 round
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration17 named
ADAllan DrazenPRESIDENT OF GENESIS CAPITAL PARTNERS, INC., MANAGERiFiling they signed
ASAndrew SmithExecutive Officer, DirectoriFiling they signed
BLBrian LaibowExecutive Committee memberiFiling they signed
BFBrittany FairweatherExecutive OfficeriFiling they signed
CACharles August JerabekExecutive Officer, PromoteriFiling they signed
EKEli KentMember of the Manager's Manager BoardiFiling they signed
ESEmily StephensDirectoriFiling they signed
JKJason KellerDirectoriFiling they signed
JAJohn August CantyExecutive Officer, PromoteriFiling they signed
NSNorma SmithDirectoriFiling they signed
RDRobert DeFrancoPrincipal and the Chief Investment Officer and Chief Risk Officer of the Issuer's Manager and a member of the Manager's Manager BoardiFiling they signed
RWRobert WasmundExecutive Officer, DirectoriFiling they signed
TCThomas CroneExecutive OfficeriFiling they signed
TWTrixy WeissVICE PRESIDENT OF GENESIS CAPITAL PARTNERS, INC., MANAGERiFiling they signed
WAWilliam August BischoffExecutive Officer, PromoteriFiling they signed
WMWilliam MoodyMember of the Manager's Manager BoardiFiling they signed
ZPZhijian PengDirectoriFiling they signed
We also hold 21 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Affinium PharmaceuticalsBought by Debiopharm GroupUndisclosedFeb 2014
An exit counts when it came after the firm's first round in the company. From historical deal records.